These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intratumoral Cell Heterogeneity in Patient-Derived Glioblastoma Cell Lines Revealed by Single-Cell RNA-Sequencing. Arbatskiy M; Balandin D; Churov A; Varachev V; Nikolaeva E; Mitrofanov A; Bekyashev A; Tkacheva O; Susova O; Nasedkina T Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126040 [TBL] [Abstract][Full Text] [Related]
4. Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis. Xiong Z; Yang Q; Li X CNS Neurosci Ther; 2020 Sep; 26(9):981-989. PubMed ID: 32488994 [TBL] [Abstract][Full Text] [Related]
5. Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging. Rios AC; Capaldo BD; Vaillant F; Pal B; van Ineveld R; Dawson CA; Chen Y; Nolan E; Fu NY; ; Jackling FC; Devi S; Clouston D; Whitehead L; Smyth GK; Mueller SN; Lindeman GJ; Visvader JE Cancer Cell; 2019 Apr; 35(4):618-632.e6. PubMed ID: 30930118 [TBL] [Abstract][Full Text] [Related]
7. "Zooming in" on Glioblastoma: Understanding Tumor Heterogeneity and its Clinical Implications in the Era of Single-Cell Ribonucleic Acid Sequencing. Khalafallah AM; Huq S; Jimenez AE; Serra R; Bettegowda C; Mukherjee D Neurosurgery; 2021 Feb; 88(3):477-486. PubMed ID: 32674143 [TBL] [Abstract][Full Text] [Related]
8. Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma. Natsume A; Ito M; Katsushima K; Ohka F; Hatanaka A; Shinjo K; Sato S; Takahashi S; Ishikawa Y; Takeuchi I; Shimogawa H; Uesugi M; Okano H; Kim SU; Wakabayashi T; Issa JP; Sekido Y; Kondo Y Cancer Res; 2013 Jul; 73(14):4559-70. PubMed ID: 23720055 [TBL] [Abstract][Full Text] [Related]
9. Chromatin landscapes reveal developmentally encoded transcriptional states that define human glioblastoma. Mack SC; Singh I; Wang X; Hirsch R; Wu Q; Villagomez R; Bernatchez JA; Zhu Z; Gimple RC; Kim LJY; Morton A; Lai S; Qiu Z; Prager BC; Bertrand KC; Mah C; Zhou W; Lee C; Barnett GH; Vogelbaum MA; Sloan AE; Chavez L; Bao S; Scacheri PC; Siqueira-Neto JL; Lin CY; Rich JN J Exp Med; 2019 May; 216(5):1071-1090. PubMed ID: 30948495 [TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA-seq reveals that glioblastoma recapitulates a normal neurodevelopmental hierarchy. Couturier CP; Ayyadhury S; Le PU; Nadaf J; Monlong J; Riva G; Allache R; Baig S; Yan X; Bourgey M; Lee C; Wang YCD; Wee Yong V; Guiot MC; Najafabadi H; Misic B; Antel J; Bourque G; Ragoussis J; Petrecca K Nat Commun; 2020 Jul; 11(1):3406. PubMed ID: 32641768 [TBL] [Abstract][Full Text] [Related]
11. Beyond sequence variation: assessment of copy number variation in adult glioblastoma through targeted tumor somatic profiling. McNulty SN; Cottrell CE; Vigh-Conrad KA; Carter JH; Heusel JW; Ansstas G; Dahiya S Hum Pathol; 2019 Apr; 86():170-181. PubMed ID: 30594748 [TBL] [Abstract][Full Text] [Related]
12. Computational Characterization of Suppressive Immune Microenvironments in Glioblastoma. Luoto S; Hermelo I; Vuorinen EM; Hannus P; Kesseli J; Nykter M; Granberg KJ Cancer Res; 2018 Oct; 78(19):5574-5585. PubMed ID: 29921698 [TBL] [Abstract][Full Text] [Related]
13. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
14. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
15. Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression. Lu IN; Dobersalske C; Rauschenbach L; Teuber-Hanselmann S; Steinbach A; Ullrich V; Prasad S; Blau T; Kebir S; Siveke JT; Becker JC; Sure U; Glas M; Scheffler B; Cima I Nat Commun; 2021 Jun; 12(1):3895. PubMed ID: 34162860 [TBL] [Abstract][Full Text] [Related]
16. Unravelling glioblastoma heterogeneity by means of single-cell RNA sequencing. Hernández Martínez A; Madurga R; García-Romero N; Ayuso-Sacido Á Cancer Lett; 2022 Feb; 527():66-79. PubMed ID: 34902524 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma. Hasan T; Caragher SP; Shireman JM; Park CH; Atashi F; Baisiwala S; Lee G; Guo D; Wang JY; Dey M; Wu M; Lesniak MS; Horbinski CM; James CD; Ahmed AU Cell Death Dis; 2019 Mar; 10(4):292. PubMed ID: 30926789 [TBL] [Abstract][Full Text] [Related]
18. Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy. Syga S; Jain HP; Krellner M; Hatzikirou H; Deutsch A PLoS Comput Biol; 2024 Aug; 20(8):e1012003. PubMed ID: 39121170 [TBL] [Abstract][Full Text] [Related]
19. Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response. Johnson KC; Anderson KJ; Courtois ET; Gujar AD; Barthel FP; Varn FS; Luo D; Seignon M; Yi E; Kim H; Estecio MRH; Zhao D; Tang M; Navin NE; Maurya R; Ngan CY; Verburg N; de Witt Hamer PC; Bulsara K; Samuels ML; Das S; Robson P; Verhaak RGW Nat Genet; 2021 Oct; 53(10):1456-1468. PubMed ID: 34594038 [TBL] [Abstract][Full Text] [Related]
20. A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas. Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Takajo T; Kirishima M; Hamada T; Matsuo K; Fujio S; Hanada T; Hosoyama H; Yonenaga M; Sakamoto A; Hiraki T; Tanimoto A; Yoshimoto K Cancer Sci; 2020 Oct; 111(10):3902-3911. PubMed ID: 32748499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]